Suppr超能文献

核糖体 S10 基因在对替加环素敏感性降低的金黄色葡萄球菌临床株中的突变。

Mutations at the Ribosomal S10 Gene in Clinical Strains of Staphylococcus aureus with Reduced Susceptibility to Tigecycline.

机构信息

National Reference Centre-Staphylococcus aureus, Department of Microbiology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium

National Reference Centre-Staphylococcus aureus, Department of Microbiology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

出版信息

Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01852-17. Print 2018 Jan.

Abstract

Mutations on the tip of the extended loop of the ribosomal S10 protein have been associated to tigecycline (TGC) resistance in passaged mutants of different bacteria species. This study described the first two clinical TGC-resistant isolates with these mutations. One strain (TGC MIC = 2 mg/liter) had a 12-nucleotide deletion affecting residues 56 to 59 (HKYK) of the S10 protein. The second strain (TGC MIC = 1 mg/liter) had amino acid substitutions (K57M and Y58F) previously described in passaged mutants.

摘要

核糖体 S10 蛋白延伸环尖端的突变与不同细菌种属传代突变株中的替加环素(TGC)耐药性有关。本研究描述了这两种具有这些突变的首个临床 TGC 耐药分离株。一株(TGC MIC = 2 毫克/升)的 S10 蛋白有影响残基 56 到 59(HKYK)的 12 个核苷酸缺失。第二株(TGC MIC = 1 毫克/升)的氨基酸取代(K57M 和 Y58F)之前在传代突变株中已有描述。

相似文献

引用本文的文献

2
Prevalence of (X4) in From Duck Farms in Southeast China.中国东南部鸭场中(X4)的流行情况。
Front Microbiol. 2021 Aug 23;12:716393. doi: 10.3389/fmicb.2021.716393. eCollection 2021.
8
as a Prominent Resource of Future Anti-MRSA Drugs.作为未来抗耐甲氧西林金黄色葡萄球菌药物的重要资源。
Front Microbiol. 2018 Sep 24;9:2221. doi: 10.3389/fmicb.2018.02221. eCollection 2018.

本文引用的文献

2
Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance.四环素抗性蛋白产生替加环素抗性的潜力。
Antimicrob Agents Chemother. 2015 Nov 23;60(2):789-96. doi: 10.1128/AAC.02465-15. Print 2016 Feb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验